The client is a major Ghanaian pharmaceutical manufacturing entity. The company has its own manufacturing and laboratory centre. Following a vertical integration policy, the company intends to produce medical-grade corn for starch and requires international support to perform a pre-feasibility study on a targeted site of 1 000 ha.
The client is specialized in the pharmaceutical industry and has no in-house agronomic capacity. The selected site is far away from the transformation unit and the client requires a comprehensive review of its agronomic and economics strategies.
In less than two months the client was provided with the pre-feasibility study including an updated Business Plan, relying on realistic agronomic yields, income assumptions and an achievable investment plan.
FGM optimized the site assessment by preparing the investigation prior to going on site with:
FGM findings and recommendations were compiled in a detailed pre-feasibility report including:
New Global Pharmaceuticals